search
Back to results

Aerobic Training in Patients With Spinal Muscular Atrophy Type III

Primary Purpose

Spinal Muscular Atrophy

Status
Completed
Phase
Not Applicable
Locations
Denmark
Study Type
Interventional
Intervention
Aerobic conditioning
Sponsored by
Rigshospitalet, Denmark
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Spinal Muscular Atrophy

Eligibility Criteria

18 Years - 65 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Genetically verified SMAIII

Exclusion Criteria:

  • other serious medical conditions that could confound the interpretation of results and
  • regular exercise more than one hour weekly

Sites / Locations

  • Rigshospitalet, Neuromuscular Research Unit, 3342

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

12 weeks of aerobic conditioning

Arm Description

12 weeks of aerobic conditioning, a total 42 sessions of 30min exercise on a stationary cycle ergometer

Outcomes

Primary Outcome Measures

Changes in oxidative capacity with aerobic conditioning in SMAIII patients

Secondary Outcome Measures

Changes in maximal workload capacity with aerobic conditioning in SMAIII patients
The maximal workload capacity was defined as: The maximal resistance the subject was able to work at, during an incremental load exercise test, performed on a cycle ergometer.
Changes in isometric muscle strength with aerobic conditioning in SMAIII patients
Isometric muscle strength was measured using a hand held dynamometer testing the strengths in the gastrocnemius and the quadriceps muscles of the legs. Strengths in the biceps and deltoid muscles were used as controls.
Changes in daily function with aerobic conditioning in SMAIII patients
Changes in daily function was measured as changes in activities af daily living (ADL) reported in a ADL-questionnaire

Full Information

First Posted
August 22, 2013
Last Updated
October 28, 2015
Sponsor
Rigshospitalet, Denmark
search

1. Study Identification

Unique Protocol Identification Number
NCT02003937
Brief Title
Aerobic Training in Patients With Spinal Muscular Atrophy Type III
Official Title
Aerobic Training Improves Oxidative Capacity, But Not Function in Spinal Muscular Atrophy III
Study Type
Interventional

2. Study Status

Record Verification Date
October 2015
Overall Recruitment Status
Completed
Study Start Date
September 2009 (undefined)
Primary Completion Date
September 2010 (Actual)
Study Completion Date
September 2010 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Rigshospitalet, Denmark

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Spinal muscular atrophy type III, (SMAIII) is a disease in the nerve cells in the spinal cord which leads to to progressive muscle weakness and atrophy. No effective treatment is available for SMA. We have previously shown that patients with muscular dystrophies improve oxidative capacity (VO2max), muscle strength and daily function by aerobic conditioning. Patients with SMAIII share many clinical features with these conditions, although the mechanism of muscle weakness is different. In this study, we investigated how patients with SMAIII respond to aerobic training. 6 patients and 9 healthy age- and sex-matched controls completed a 12 weeks training program. Subjects performed a total of 42 training session of 30 min on a stationary cycle ergometer at home. The work intensity was moderate and set to match a target heart rate. Training induced an increase without inducing muscle damage. However, training-induced fatigue was a major complaint in all patients, and caused one patient to drop out, increased the need for sleep in three patients and two had to modify the training program. The fatigue limits the use of this therapy. The training-induced fatigue, which is not encountered in muscle diseases, warrants investigations into alternative training methods to improve quality of life in patients with SMAIII.
Detailed Description
Spinal muscular atrophy type III, (SMAIII) is a recessively inherited disease in the lower motor neuron in the anterior horn of spinal cord leading to to progressive muscle weakness and atrophy. Currently there is no effective treatment available for SMA. We have previously shown that patients with muscular dystrophies improve oxidative capacity (VO2max), muscle strength and daily function by aerobic conditioning. Patients with SMAIII share many clinical features with these conditions, although the mechanism of muscle weakness is different. In this study, we investigated how patients with SMAIII respond to aerobic training. 6 patients and 9 healthy age- and sex-matched controls completed a 12 weeks training program. Subjects performed a total of 42 training session of 30 min on a stationary cycle ergometer at home. The work intensity was moderate and set to match a target heart rate. VO2max was measured during a incremental exercise test using indirect calorimetry before and after the training period. Functional tests adressing patients walking and stair climbing abilities, were performed before and after the training period. Changes in activities of daily living was adressed in a standardized questionnaire after the training period. Training induced an increase without inducing muscle damage. There were no changes in patients' functional capacities. However, training-induced fatigue was a major complaint in all patients, and caused one patient to drop out, increased the need for sleep in three patients and two had to modify the training program. The fatigue limits the use of this therapy. The training-induced fatigue, which is not encountered in muscle diseases, warrants investigations into alternative training methods to improve quality of life in patients with SMAIII.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Spinal Muscular Atrophy

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
15 (Actual)

8. Arms, Groups, and Interventions

Arm Title
12 weeks of aerobic conditioning
Arm Type
Experimental
Arm Description
12 weeks of aerobic conditioning, a total 42 sessions of 30min exercise on a stationary cycle ergometer
Intervention Type
Behavioral
Intervention Name(s)
Aerobic conditioning
Intervention Description
Subjects performed 12 weeks of aerobic training on a stationary cycle ergometer. Subjects compleeted a total of 42 training sessions of 30min. exercise at an individually adjusted moderate workload.
Primary Outcome Measure Information:
Title
Changes in oxidative capacity with aerobic conditioning in SMAIII patients
Time Frame
After 12 weeks of aerobic training
Secondary Outcome Measure Information:
Title
Changes in maximal workload capacity with aerobic conditioning in SMAIII patients
Description
The maximal workload capacity was defined as: The maximal resistance the subject was able to work at, during an incremental load exercise test, performed on a cycle ergometer.
Time Frame
After 12 weeks of aerobic conditioning
Title
Changes in isometric muscle strength with aerobic conditioning in SMAIII patients
Description
Isometric muscle strength was measured using a hand held dynamometer testing the strengths in the gastrocnemius and the quadriceps muscles of the legs. Strengths in the biceps and deltoid muscles were used as controls.
Time Frame
After 12 weeks of aerobic conditioning
Title
Changes in daily function with aerobic conditioning in SMAIII patients
Description
Changes in daily function was measured as changes in activities af daily living (ADL) reported in a ADL-questionnaire
Time Frame
After 12 weeks of aerobic training

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Genetically verified SMAIII Exclusion Criteria: other serious medical conditions that could confound the interpretation of results and regular exercise more than one hour weekly
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Karen L Madsen, M.Sc
Organizational Affiliation
Rigshospitalet, Denmark
Official's Role
Principal Investigator
Facility Information:
Facility Name
Rigshospitalet, Neuromuscular Research Unit, 3342
City
Copenhagen E
ZIP/Postal Code
2100
Country
Denmark

12. IPD Sharing Statement

Learn more about this trial

Aerobic Training in Patients With Spinal Muscular Atrophy Type III

We'll reach out to this number within 24 hrs